盘龙药业：酮洛芬凝胶贴膏获临床试验批准

Core Viewpoint - Panlong Pharmaceutical has received approval from the National Medical Products Administration for the clinical trial of Ketoprofen gel patch, which is intended for pain relief in various conditions [1] Group 1: Product Details - The approved drug is a Ketoprofen gel patch, classified as a Class 3 chemical drug [1] - The patch is designed for local application, with a size of 14cm x 10cm, containing 10g of gel and 30mg of Ketoprofen [1] - Indications for the drug include osteoarthritis, periarthritis of the shoulder, tendonitis, tenosynovitis, lateral epicondylitis (tennis elbow), muscle pain, and swelling and pain due to trauma [1] Group 2: Regulatory Approval - The clinical trial approval notification number is 2026LP00383 [1] - The approval allows the company to conduct clinical trials aimed at pain relief [1]